/
Licensed Care / Search Licensing Programs / Assisted Living Facility Search
102 Desmond Plaza SE
LEESBURG, VA 20175
571-224-9516
| Inspection Dates: | 10/07/2025 |
|---|---|
| Complaint Related: | NO |
| Inspector: | Amanda Velasco: (703) 397-4587 |
Type of inspection: Complaint Date of inspection and time the licensing inspector was on-site at the facility for each day of the inspection: 10/07/2025, 9:30 A.M. To 10:30 A.M. The Acknowledgement of Inspection form was signed and left at the facility for each date of the inspection. A complaint was received by VDSS Division of Licensing on 10/03/2025 regarding allegations in the area(s) of: Resident Care and Related Services, Complaint Investigation. Number of residents present at the facility at the beginning of the inspection: 43 The licensing inspector completed a tour of the physical plant that included the building and grounds of the facility. Number of resident records reviewed: 1 Number of staff records reviewed: 2 Number of interviews conducted with residents:0 Number of interviews conducted with staff: 2 Observations by licensing inspector: Lunch and activities. Additional Comments/Discussion: none. The evidence gathered during the investigation supported the allegation(s) of non-compliance with standard(s) or law, and violation(s) were issued. Any violation(s) not related to the complaint but identified during the course of the investigation can also be found on the violation notice. The licensee has the opportunity to submit a plan of correction to indicate how the cited violation(s) will be addressed in order to return the facility to compliance and maintain future compliance with applicable standard(s) or law. If the licensee wishes to provide a plan of correction: (i) type the plan on a separate Word document, (ii) identify the standard violation number being addressed, (iii) include the date the violation will be corrected, (IV) do not include any names or confidential information, and (V) return to the licensing inspector by email within five (5) business days of the exit interview. Compliance with all applicable regulations and law shall be maintained and any areas of noncompliance must be corrected. Within 15 calendar days of your receipt of the inspection findings (inspection summary, violation notice, and supplemental information), you may request a review and discussion of these findings with the inspector's immediate supervisor. To make a request for review and discussion, you must contact the licensing supervisor at the regional licensing office that serves your geographical area. Regardless of whether a supervisory review has been requested, the results of the inspection will be posted to the DSS public website within 5 business days of your receipt of the Inspection Summary and/ or Violation Notice. The department's inspection findings are subject to public disclosure. Please Note: A copy of the findings of the most recent inspection are required to be posted on the premises of the facility. For more information about the VDSS Licensing Programs, please visit: www.dss.virginia.gov Should you have any questions, please contact Jacquelyn Kabiri, Licensing Inspector at (703) 397-3017 or by email at Jacquelyn.Kabiri@dss.virginia.gov
Description: Based on documentation and interview, the facility failed to implement their written plan for medication management. Evidence: 1. On 10/03/2025, the Licensing Inspector (LI) received an APS report stating that resident 1 arrived at INOVA Hospital on 10/02/2025 with two Exelon (Rivastigmine 9.5 mg) patches on their arm, neither of which had a written indication of the date or time. 2. Resident 1’s October Electronic Administration Record (eMAR) was reviewed during the inspection. Resident 1’s e-MAR states that a Rivastigmine 9.5 mg patch was to be applied to the skin once daily every morning. 3. Staff 2 provided the medication management plan to include the general and specific procedures on the administration of medication. 4 In an interview with the LI, Staff 2 confirmed that the resident arrived at the hospital wearing two Rivastigmine 9.5 mg patches. They also stated that the procedure is to remove the old patch before applying a new one. Furthermore, Staff 2 clarified that the integrity of the patch material prohibits using a marker to indicate the date and time of placement.
Training was provided to all Medtechs immediately after the incident was reported to us by the family on 10/3 regarding following written plan for medication management. Director of Nursing will conduct random medication administration audits to ensure compliance.
Description: Based on record review and staff interview, the facility failed to administer medication in accordance with the physician's or other prescriber’s instructions. Evidence: 1. Upon record review during the onsite inspection on 10/07/2025, Resident 1 has a physician order dated 02/26/2025, Rivastigmine Dis 9.5 mg, apply a new patch to the skin once daily every morning. 2. In an interview with the LI, staff 2 confirmed that resident 1 arrived at the hospital on 10/02/2025 wearing two Rivastigmine 9.5 mg patches.
Initial training was provided to all Medtechs immediately after the incident. Additional training was also provided during all hands Medtech training regarding following medication administration in accordance with the physician’s order on 10/23.
Find my local department